REQUEST A DEMO
Total
USD $0.00
Search more companies

Variopharma S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Variopharma S.R.O. Profile Updated: December 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Variopharma S.R.O. is an enterprise based in Czech Republic. Its main office is in Prague. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on November 07, 2019. Variopharma S.R.O. currently employs 6 - 9 (2025) people. From the latest financial highlights, Variopharma S.R.O. reported a net sales revenue increase of 12.22% in 2024. Its’ total assets recorded a growth of 8.75%. The enterprise’s net profit margin increased by 2.88% in 2024.

Headquarters
Rybna 716/24
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Variopharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Variopharma S.R.O. report to view the information.
Registered Capital:
Purchase the Variopharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Variopharma S.R.O. report to view the information.
Incorporation Date:
November 07, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Variopharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
12.22%
Total operating revenue
16.23%
Operating profit (EBIT)
83.43%
EBITDA
96.46%
Net Profit (Loss) for the Period
326.52%
Total assets
8.75%
Total equity
28.41%
Operating Profit Margin (ROS)
2.79%
Net Profit Margin
2.88%
Return on Equity (ROE)
6.81%
Debt to Equity Ratio
-37%
Quick Ratio
-0.62%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?